Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureBom Lee, Jeeeun Yoo, Hyeon-Jeong Jeon, Yu Jeong Kim, Xiaoliang Cheng, Seong-Eun Kim, James J. Moon, Yonghyun Lee
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
10.1038/s41575-019-0258-z · 2020
Intestinal barriers protect against disease
10.1126/science.aat0835 · 2018
Dysbiosis and the immune system
10.1038/nri.2017.7 · 2017
Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host-microbiome relationships
10.1016/j.cell.2019.07.045 · 2019
Intestinal homeostasis and its breakdown in inflammatory bowel disease
10.1038/nature10208 · 2011
Unravelling the pathogenesis of inflammatory bowel disease
10.1038/nature06005 · 2007
Understanding the therapeutic toolkit for inflammatory bowel disease, nature reviews
2025
NF-κB in biology and targeted therapy: new insights and translational implications
10.1038/s41392-024-01757-9 · 2024
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
10.1016/j.addr.2021.114021 · 2021
Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1038/s41563-019-0462-9 · 2020
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study
10.1053/gast.2001.26279 · 2001
Conventional medical management of inflammatory bowel disease
10.1053/j.gastro.2011.02.045 · 2011
Immune regulation by glucocorticoids
10.1038/nri.2017.1 · 2017
Anti-inflammatory agents: present and future
10.1016/j.cell.2010.02.043 · 2010
Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases
10.1097/mib.0000000000000332 · 2015
Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage
10.1172/jci155880 · 2024
The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice
10.1016/j.bcp.2016.07.010 · 2016
Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro
10.1080/003655201750305495 · 2001
Corticosteroid therapy augments gastroduodenal permeability to sucrose
10.1111/j.1572-0241.1998.00697.x · 1998
Steroid use and misuse: a key performance indicator in the management of IBD
10.1136/flgastro-2019-101288 · 2021
Chronic steroid use: an overlooked impact on patients with inflammatory bowel disease
10.1002/jgh3.12841 · 2022
Unmet needs in inflammatory bowel disease, current research in pharmacology and drug discovery
2021
Inflammatory bowel disease: long-term therapeutic challenges
10.1080/17474124.2019.1685872 · 2019
Long-term systemic corticosteroid exposure: a systematic literature review
10.1016/j.clinthera.2017.09.011 · 2017
Multistimuli-responsive bilirubin nanoparticles for anticancer therapy
10.1002/anie.201604858 · 2016
Bilirubin nanoparticles as a nanomedicine for anti-inflammation therapy
10.1002/anie.201602525 · 2016
PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation
10.1016/j.biomaterials.2017.04.029 · 2017
Thymus degeneration and regeneration
10.3389/fimmu.2021.706244 · 2021
Evaluation of Caco-2 and human intestinal epithelial cells as in vitro models of colonic and small intestinal integrity
2022
Development of an inflammation-triggered in vitro "leaky gut" model using Caco-2/HT29-MTX-E12 combined with macrophage-like THP-1 cells or primary human-derived macrophages
10.3390/ijms24087427 · 2023
Gut microbiome structure and metabolic activity in inflammatory bowel disease
10.1038/s41564-018-0306-4 · 2019
The influence of Akkermansia muciniphila on intestinal barrier function
10.1186/s13099-024-00635-7 · 2024
The role of Akkermansia muciniphila in inflammatory bowel disease: current knowledge and perspectives
10.3389/fimmu.2022.1089600 · 2023
Induction of colonic regulatory T cells by indigenous Clostridium species
10.1126/science.1198469 · 2011
A single species of Clostridium subcluster XIVa decreased in ulcerative colitis patients
10.1097/mib.0000000000000972 · 2016
Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells
10.4049/jimmunol.176.2.1228 · 2006
Anti-inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control
2022
Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis
10.1212/wnl.53.9.2093 · 1999
Modulation of intestinal barrier function by glucocorticoids: lessons from preclinical models
10.1016/j.phrs.2022.106056 · 2022
Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases
10.1016/j.jconrel.2014.03.039 · 2014
Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform
10.1128/aem.01043-13 · doi-reference
Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities
10.1128/aem.01541-09 · doi-reference
Fecal microbiota transplantation eliminates Clostridium difficile in a murine model of relapsing disease
10.1128/iai.00459-15 · doi-reference
Dextran sulfate sodium (DSS)-induced colitis in mice
10.1002/0471142735.im1525s104 · doi-reference
Gut microbiome standardization in control and experimental mice
10.1002/cpim.25 · doi-reference
Lipoic acid capped silver nanoparticles: a facile route to covalent protein capping and oxidative stability within biological systems
10.1039/d0ra07080g · doi-reference
Modeling the oxidative consumption of curcumin from controlled released poly (beta-amino ester) microparticles in the presence of a free radical generating system
10.1093/rb/rbz002 · doi-reference
Protective effects of extracts from six local strains of Pyropia yezoensis against oxidative damage in vitro and in zebrafish model
10.4490/algae.2020.35.5.14 · doi-reference
Dexamethasone-loaded polymeric nanoconstructs for monitoring and treating inflammatory bowel disease
10.7150/thno.18183 · doi-reference
Oral delivery of tunable oxidation-responsive budesonide-loaded nanoparticles enhances inflammation modulation in intestinal colitis
10.1016/j.jconrel.2025.113948 · doi-reference